Streetbeat News

Stock Prices

CDRE

Cadre Holdings (NYSE:CDRE) reported Q2 earnings per share of $0.31, beating the analyst estimate of $0.27 by 14.81%. Sales were $144.31 million, surpassing the $142.05 million estimate and marking a 19.18% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:20 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets are trading marginally higher with Bitcoin, Ethereum, and Dogecoin showing gains. Notable developments include a new Trump-themed coin, a CBOE application for Bitcoin ETF options, and Putin's approval of crypto mining in Russia. Analysts predict Bitcoin could reach $100,000 by the end of 2024.

Portfolio Pulse from Khyathi Dalal

August 09, 2024 | 8:17 pm

BMI

Badger Meter has announced an increase in its quarterly dividend from $0.27 to $0.34 per share.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:15 pm

YUMC

Yum China Holdings (NYSE:YUMC) has seen a 9.58% decrease in its short percent of float, now at 2.36% of all regular shares available for trading. This is lower than the peer group average of 10.38%. It would take traders 4.4 days to cover their short positions on average.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 8:15 pm

OCGN

Ocugen's (NYSE:OCGN) short interest has risen by 15.83%, with 24.37% of its float sold short. This is significantly higher than its peers' average of 11.57%. It would take traders 11.68 days to cover their short positions.

Portfolio Pulse from Benzinga Insights

August 09, 2024 | 8:15 pm

CLSK

Cleanspark (NASDAQ:CLSK) reported Q3 earnings per share (EPS) of $(1.03), significantly missing the analyst consensus estimate of $(0.04). The company also reported quarterly sales of $104.11 million, which fell short of the $110.88 million estimate. Despite the misses, sales increased by 128.69% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:14 pm

CTMX

CytomX Therapeutics has filed a $250 million mixed securities shelf with the SEC, allowing the company to issue various types of securities over time.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:11 pm

MSGM

Motorsport Games (NASDAQ:MSGM) reported Q2 2024 GAAP EPS of $0.87, beating the estimate of $0.69 by 26.09%. The company also reported sales of $1.881 million, surpassing the estimate of $1.556 million by 20.85%. This represents an 8.17% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:11 pm

ATXI

Avenue Therapeutics (NASDAQ:ATXI) reported a Q2 EPS of $(6.43), significantly missing the analyst consensus estimate of $(1.05) by 512.38%. This represents an 83.4% improvement over the $(38.74) per share loss from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:10 pm

HUMA

Humacyte shares are trading lower after the company announced that the FDA will require additional time to complete its review of the BLA for ATEV in the treatment of vascular trauma.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:10 pm